With generous support of the William K. Warren Foundation, the mission of this premier drug discovery and development center is:
• To be a state-of-the-art resource for a highly productive and renowned group of faculty with research interests overlapping with drug discovery.
• To expand of the bandwidth of our members and enable multidisciplinary projects beyond our current capabilities by bridging to the University’s disease-focused research centers and institutes, external partners including the Indiana Drug Discovery Alliance, the Indiana CTSI, academic screening facilities, and pharmaceutical industry partners.
• To organize the products and byproducts of past, current, and future chemical research to create the Notre Dame Chemical Compound Collection and to promote biological evaluation of these entities through internal collaborations and external partnerships, initiating the translation of discoveries from chemical synthesis to patient outcomes.
• To enhance all stages of the process from basic discovery to applied and translational research, to support collaborative pre-clinical and clinical opportunities, and to promote a culture of innovation and entrepreneurship by exploiting resource throughout the campus and the region.
Universities, governments and private industry are working together to more rapidly translate scientific breakthroughs into medicines that reach patients instead of disappearing in the “valley of death.” - Abbvie (February 2016)
SPECIAL OPPORTUNITY: Eli Lilly Faculty Fellowship in Drug Discovery
In an effort to further our relationship with Eli Lilly, a world leader in the development of new medicines and new models for scientific innovation, a number of Notre Dame administrative units have come together to create a fellowship program to support faculty who wish to gain unique knowledge and practical experience in pharmaceutical industry. Faculty researchers from across the university with an interest in the drug discovery process are invited to spend a period of at least 2-3 months embedded within the chemistry program at Eli Lilly & Co, Indianapolis, IN. As a visiting scholar, the Lilly Fellow will experience firsthand, the drug discovery and development process, by shadowing a team of Lilly scientists and project managers. Projects will align within areas of Lilly’s current drug discovery interests (oncology, diabetes, neurodegeneration, autoimmune disorders, and pain). Individual project assignments will be determined by mutual agreement of the faculty researcher and their host scientist at Lilly. ND-Lilly fellows will have the opportunity to consult on project related issues, collaborate with Lilly scientists on research questions, present seminars on topics of mutual interests, and stimulate new connections between Lilly and Notre Dame researchers.
To encourage tenured, tenure-track, and research faculty to participate in this exciting, new opportunity, a stipend will be provided to help offset the costs of local housing. The program has developed by representatives from ND-Research, the Dean’s offices in the Colleges of Science and Engineering, the Harper Cancer Research Institute, the Boler-Parseghian Center for Rare and Neglected Diseases and the Warren Family Research Center for Drug Discovery and Development.
ND-Research is now accepting applications for the Eli Lilly Fellowship Program which will be awarded on a rolling basis. The formal program will begin in the summer 2016. Fellowship requests from tenured or tenure-track faculty during the academic year must be approved through the normal departmental sabbatical leave policy. Interested applicants should submit a letter of interest including a proposed start and end date, and an NIH-style biosketch addressed to Professor Rich Taylor.
The Warren Center is please to announce that Professor Haifeng Gao (CHEM) has been appointed our inaugural Lilly Faculty Fellow. During the Summer 2016 he will be working at Eli Lilly in Indianapolis. Haifeng will be learning about Lilly's effort to develop new treatments for diabetes and Alzheimer disease. In addition, he will be learning their perspective on drug formulation and the use of polymers in current drug development.
The Warren Center will build upon a core group of highly productive, externally funded research programs in drug discovery. Although the Center’s current and historical research strength is within the Department of Chemistry & Biochemistry, membership within the Center includes all interested tenure-track and research faculty from across the campus of the University of Notre Dame as well as Indiana University School of Medicine-South Bend. For a survey of some of our recent efforts please visit our research and collaborations page.
Drug Discovery Service Facilities and Service Partnerships
The Warren Center offers a number of services to support drug discovery and development through internal core facilities and external partnerships.